For media-related enquiries, please contact
Corporate Communications
Australia and New Zealand
[email protected]
2024
February
AbbVie announces Country Head change in New Zealand
Read full media release here.
2023
May
Experts meet to spur on New Zealand’s hepatitis C elimination plan
Read full media release here.
2022
July
5,000 New Zealanders have now received funded access to MAVIRET for the treatment of hepatitis C
Read full media release here.
May
AbbVie appoints Kylie Pennington as Country Head, New Zealand
Read full media release here.
2021
September
Pharmac funds additional treatment option for eligible New Zealanders living with rheumatoid arthritis
Read full media release here.
2020
May
AbbVie Completes Transformative Acquisition of Allergan
Read full media release here.
March
AbbVie New Zealand - Local Response to COVID-19
Read here.
2019
December
Chris Stemple Appointed General Manager AbbVie ANZ
Read full media release here.
October
PHARMAC funds new treatment option for New Zealanders living with chronic lymphocytic leukaemia
Read full media release here.
October
PHARMAC funds new treatment option for New Zealanders living with painful inflammatory skin condition
Read full media release here.
September
PHARMAC Funds Treatment for a Leading Cause of Preventable Blindness
Read full media release here.
June
AbbVie ANZ Appoints New Medical Director
Read full media release here.
February
New treatment available to New Zealanders seeking a viral cure for Hepatitis C
Read full media release here.